Sinco Pharmaceuticals Holdings Limited (HKG:6833)
Hong Kong
· Delayed Price · Currency is HKD 0.189
0.00 (0.00%)
Apr 28, 2026, 2:20 PM HKT
HKG:6833 Revenue
In the year 2025, Sinco Pharmaceuticals Holdings had annual revenue of 2.08B CNY, down -26.11%. Sinco Pharmaceuticals Holdings had revenue of 888.76M in the half year ending December 31, 2025, a decrease of -38.70%.
Revenue
2.08B CNY
Revenue Growth
-26.11%
P/S Ratio
0.17
Revenue / Employee
7.99M CNY
Employees
261
Market Cap
384.22M HKD
Revenue Chart
* This company reports financials in CNY.
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 2.08B | -736.75M | -26.11% |
| Dec 31, 2024 | 2.82B | 281.26M | 11.07% |
| Dec 31, 2023 | 2.54B | 268.56M | 11.82% |
| Dec 31, 2022 | 2.27B | 247.45M | 12.23% |
| Dec 31, 2021 | 2.02B | -25.75M | -1.26% |
| Dec 31, 2020 | Pro | Pro | Pro |
| Dec 31, 2019 | Pro | Pro | Pro |
| Dec 31, 2018 | Pro | Pro | Pro |
| Dec 31, 2017 | Pro | Pro | Pro |
| Dec 31, 2016 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| ClouDr Group | 1.81B |
| Ziyuanyuan Holdings Group | 535.97M |
| Charmacy Pharmaceutical | 4.88B |
| Wanjia Group Holdings | 163.70M |
| China Health Group | 39.87M |
| Tai United Holdings | 125.65M |
| Sipai Health Technology | 2.30B |
| Grand Brilliance Group Holdings | 105.25M |